US Patent 7700631 Phosphodiesterase 4 inhibitors
Patent 7700631 was granted and assigned to Memory Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+189 characters)
Article
Patent abstract
PDE4 inhibition is achieved by novel nitroxide compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formulas I-III:
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07700631 Phosphodiesterase 4 inhibitors US Patent 7700631 Phosphodiesterase 4 inhibitors
Infobox
Patent Number
0770063100
Patent Number
770063100
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077006310
Date of Patent
April 20, 2010
0Patent Application Number
113786150
Date Filed
March 20, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077006310
Date of Patent
April 20, 2010
0Patent Application Number
113786150
Date Filed
March 20, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07700631 Phosphodiesterase 4 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07700631
Date of patent
April 20, 2010
Patent application number
11378615
Date Filed
March 20, 2006
Patent primary examiner
Find more entities like US Patent 7700631 Phosphodiesterase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.